Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
CBT vs MPC
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Refining & Marketing
CBT vs MPC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Oil & Gas Refining & Marketing |
| Market Cap | $4.24B | $70.73B |
| Revenue (TTM) | $3.58B | $135.75B |
| Net Income (TTM) | $285M | $4.63B |
| Gross Margin | 24.8% | 8.8% |
| Operating Margin | 15.7% | 5.0% |
| Forward P/E | 13.0x | 10.9x |
| Total Debt | $1.22B | $34.36B |
| Cash & Equiv. | $258M | $3.67B |
CBT vs MPC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cabot Corporation (CBT) | 100 | 227.5 | +127.5% |
| Marathon Petroleum … (MPC) | 100 | 689.4 | +589.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBT vs MPC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 4 yrs, beta 0.78, yield 2.2%
- Lower volatility, beta 0.78, Low D/E 71.3%, current ratio 1.61x
- Beta 0.78, yield 2.2%, current ratio 1.61x
MPC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth -4.4%, EPS growth 31.5%, 3Y rev CAGR -9.2%
- 6.6% 10Y total return vs CBT's 115.7%
- -4.4% revenue growth vs CBT's -7.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -4.4% revenue growth vs CBT's -7.0% | |
| Value | Lower P/E (10.9x vs 13.0x) | |
| Quality / Margins | 8.0% margin vs MPC's 3.4% | |
| Stability / Safety | Beta 0.30 vs CBT's 0.78 | |
| Dividends | 2.2% yield, 4-year raise streak, vs MPC's 1.5% | |
| Momentum (1Y) | +70.1% vs CBT's +13.8% | |
| Efficiency (ROA) | 7.4% ROA vs MPC's 5.5%, ROIC 17.4% vs 8.3% |
CBT vs MPC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBT vs MPC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CBT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MPC is the larger business by revenue, generating $135.8B annually — 38.0x CBT's $3.6B. Profitability is closely matched — net margins range from 8.0% (CBT) to 3.4% (MPC). On growth, MPC holds the edge at +9.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.6B | $135.8B |
| EBITDAEarnings before interest/tax | $731M | $10.1B |
| Net IncomeAfter-tax profit | $285M | $4.6B |
| Free Cash FlowCash after capex | $459M | $5.7B |
| Gross MarginGross profit ÷ Revenue | +24.8% | +8.8% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +5.0% |
| Net MarginNet income ÷ Revenue | +8.0% | +3.4% |
| FCF MarginFCF ÷ Revenue | +12.8% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | +9.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.1% | +8.2% |
Valuation Metrics
CBT leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, CBT trades at a 26% valuation discount to MPC's 18.3x P/E. On an enterprise value basis, CBT's 6.7x EV/EBITDA is more attractive than MPC's 11.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.2B | $70.7B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $101.4B |
| Trailing P/EPrice ÷ TTM EPS | 13.50x | 18.26x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.04x | 10.91x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 6.71x | 11.24x |
| Price / SalesMarket cap ÷ Revenue | 1.14x | 0.53x |
| Price / BookPrice ÷ Book value/share | 2.58x | 3.07x |
| Price / FCFMarket cap ÷ FCF | 10.86x | 14.84x |
Profitability & Efficiency
CBT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
MPC delivers a 19.6% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $17 for CBT. CBT carries lower financial leverage with a 0.71x debt-to-equity ratio, signaling a more conservative balance sheet compared to MPC's 1.43x. On the Piotroski fundamental quality scale (0–9), MPC scores 7/9 vs CBT's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +16.8% | +19.6% |
| ROA (TTM)Return on assets | +7.4% | +5.5% |
| ROICReturn on invested capital | +17.4% | +8.3% |
| ROCEReturn on capital employed | +21.3% | +9.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.71x | 1.43x |
| Net DebtTotal debt minus cash | $957M | $30.7B |
| Cash & Equiv.Liquid assets | $258M | $3.7B |
| Total DebtShort + long-term debt | $1.2B | $34.4B |
| Interest CoverageEBIT ÷ Interest expense | 14.72x | 6.36x |
Total Returns (Dividends Reinvested)
MPC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MPC five years ago would be worth $42,948 today (with dividends reinvested), compared to $14,321 for CBT. Over the past 12 months, MPC leads with a +70.1% total return vs CBT's +13.8%. The 3-year compound annual growth rate (CAGR) favors MPC at 32.5% vs CBT's 7.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +21.9% | +47.3% |
| 1-Year ReturnPast 12 months | +13.8% | +70.1% |
| 3-Year ReturnCumulative with dividends | +22.5% | +132.5% |
| 5-Year ReturnCumulative with dividends | +43.2% | +329.5% |
| 10-Year ReturnCumulative with dividends | +115.7% | +664.3% |
| CAGR (3Y)Annualised 3-year return | +7.0% | +32.5% |
Risk & Volatility
Evenly matched — CBT and MPC each lead in 1 of 2 comparable metrics.
Risk & Volatility
MPC is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than CBT's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs MPC's 92.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 0.30x |
| 52-Week HighHighest price in past year | $84.60 | $261.61 |
| 52-Week LowLowest price in past year | $58.33 | $142.73 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +92.6% |
| RSI (14)Momentum oscillator 0–100 | 71.7 | 58.0 |
| Avg Volume (50D)Average daily shares traded | 374K | 2.5M |
Analyst Outlook
CBT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CBT as "Buy" and MPC as "Buy". Consensus price targets imply -4.0% upside for CBT (target: $78) vs -11.3% for MPC (target: $215). For income investors, CBT offers the higher dividend yield at 2.18% vs MPC's 1.54%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $78.00 | $214.78 |
| # AnalystsCovering analysts | 15 | 33 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +1.5% |
| Dividend StreakConsecutive years of raises | 4 | 4 |
| Dividend / ShareAnnual DPS | $1.77 | $3.74 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.0% | +4.9% |
CBT leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). MPC leads in 1 (Total Returns). 1 tied.
CBT vs MPC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CBT or MPC a better buy right now?
For growth investors, Marathon Petroleum Corporation (MPC) is the stronger pick with -4.
4% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBT or MPC?
On trailing P/E, Cabot Corporation (CBT) is the cheapest at 13.
5x versus Marathon Petroleum Corporation at 18. 3x. On forward P/E, Marathon Petroleum Corporation is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CBT or MPC?
Over the past 5 years, Marathon Petroleum Corporation (MPC) delivered a total return of +329.
5%, compared to +43. 2% for Cabot Corporation (CBT). Over 10 years, the gap is even starker: MPC returned +664. 3% versus CBT's +115. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBT or MPC?
By beta (market sensitivity over 5 years), Marathon Petroleum Corporation (MPC) is the lower-risk stock at 0.
30β versus Cabot Corporation's 0. 78β — meaning CBT is approximately 160% more volatile than MPC relative to the S&P 500. On balance sheet safety, Cabot Corporation (CBT) carries a lower debt/equity ratio of 71% versus 143% for Marathon Petroleum Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CBT or MPC?
By revenue growth (latest reported year), Marathon Petroleum Corporation (MPC) is pulling ahead at -4.
4% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Marathon Petroleum Corporation grew EPS 31. 5% year-over-year, compared to -10. 4% for Cabot Corporation. Over a 3-year CAGR, CBT leads at -4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBT or MPC?
Cabot Corporation (CBT) is the more profitable company, earning 8.
9% net margin versus 3. 0% for Marathon Petroleum Corporation — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus 4. 3% for MPC. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBT or MPC more undervalued right now?
On forward earnings alone, Marathon Petroleum Corporation (MPC) trades at 10.
9x forward P/E versus 13. 0x for Cabot Corporation — 2. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CBT: -4. 0% to $78. 00.
08Which pays a better dividend — CBT or MPC?
All stocks in this comparison pay dividends.
Cabot Corporation (CBT) offers the highest yield at 2. 2%, versus 1. 5% for Marathon Petroleum Corporation (MPC).
09Is CBT or MPC better for a retirement portfolio?
For long-horizon retirement investors, Marathon Petroleum Corporation (MPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
30), 1. 5% yield, +664. 3% 10Y return). Both have compounded well over 10 years (MPC: +664. 3%, CBT: +115. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBT and MPC?
These companies operate in different sectors (CBT (Basic Materials) and MPC (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CBT is a small-cap deep-value stock; MPC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.